FDA Inspection 1236502 — Vitalant
The FDA completed an inspection of Vitalant on Apr 4, 2024 in Oak Lawn, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oak Lawn, IL (United States)